DefinitionThis section has been translated automatically.
Diffuse, purulent, necrotizing, bacterial inflammation (subcutaneous, subfascial, intramuscular) spreading into tissue clefts with broad tissue fusion.
S.a.
EtiopathogenesisThis section has been translated automatically.
You might also be interested in
Clinical featuresThis section has been translated automatically.
LaboratoryThis section has been translated automatically.
TherapyThis section has been translated automatically.
Immobilize and, if possible, elevate affected body parts.
External therapyThis section has been translated automatically.
Internal therapyThis section has been translated automatically.
Antibiosis after antibiogram, initial dicloxacillin (e.g. InfectoStaph) 2-4 g/day in 4-6 ED. Furthermore, due to the mixed infection of staphylococcus and streptococci, effective treatment with clindamycin or flucloxacillin is possible. In severe and resistant cases, hospital admission and targeted i.v. antibiotics, initially e.g. gentamicin (e.g. refobacin) once/day 240 mg p.o. and ceftriaxone (e.g. rocephin) once/day 2 g i.v. Ultima ratio: surgical debridement
Operative therapieThis section has been translated automatically.
Incoming links (9)
Bulla repens; Fasciitis necrotizing; Glossitis phlegmonosa; Infectious diseases of the skin; Leech therapy; Leech therapy; Propicillin; Pyomyositis; Quinolinol sulphate monohydrate solution 0,1 % (nrf 11.127.);Outgoing links (11)
Abscess; Blepharitis phlegmonosa; Ceftriaxone; Edema; Erysipelas; Fasciitis necrotizing; Gentamicin; Glossitis phlegmonosa; Panaritium; Potassium permanganate; ... Show allDisclaimer
Please ask your physician for a reliable diagnosis. This website is only meant as a reference.